ZNF217: An Oncogenic Transcription Factor and Potential Therapeutic Target for Multiple Human Cancers

被引:2
|
作者
Wang, Yepeng [1 ]
Ma, Chao [2 ]
Yang, Xuekun [3 ]
Gao, Jun [1 ]
Sun, Zhigang [2 ,4 ]
机构
[1] Shandong First Med Univ, Cent Hosp, Dept Neurosurg, Jinan, Shandong, Peoples R China
[2] Shandong First Med Univ, Cent Hosp, Dept Thorac Surg, Jinan, Shandong, Peoples R China
[3] Shandong First Med Univ, Cent Hosp, Dept Neurol, Jinan, Shandong, Peoples R China
[4] Shandong First Med Univ, Cent Hosp, Dept Thorac Surg, 105 Jiefang Rd, Jinan, Shandong, Peoples R China
来源
CANCER MANAGEMENT AND RESEARCH | 2024年 / 16卷
关键词
oncogene; regulation; non-coding RNA; targeted therapy; IN-SITU HYBRIDIZATION; EPITHELIAL-MESENCHYMAL TRANSITION; P15(INK4B) TUMOR-SUPPRESSOR; BREAST-CANCER; POOR-PROGNOSIS; TGF-BETA; TISSUE MICROARRAY; REGULATING ZNF217; DRUG-RESISTANCE; NONCODING RNA;
D O I
10.2147/CMAR.S431135
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Zinc finger protein 217 (ZNF217) is one of the well-researched members of the Kruppel-like factor transcription factor family. ZNF217 possesses a characteristic structure of zinc finger motifs and plays a crucial role in regulating the biological activities of cells. Recent findings have revealed that ZNF217 is strongly associated with multiple aspects of cancer progression, impacting patient prognosis. Notably, ZNF217 is subject to regulation by non-coding RNAs, suggesting the potential for targeted manipulation of such RNAs as a robust therapeutic avenue for managing cancer in the future. The main purpose of this article is to provide a detailed examination of the role of ZNF217 in human malignant tumors and the regulation of its expression, and to offer new perspectives for cancer treatment.
引用
收藏
页码:49 / 62
页数:14
相关论文
共 50 条
  • [21] NALCN is a potential biomarker and therapeutic target in human cancers
    He, Jian
    Xu, Jie
    Chang, Zhiwei
    Yan, Jiaqin
    Zhang, Limin
    Qin, Yanru
    FRONTIERS IN GENETICS, 2023, 14
  • [22] Exploring the oncogenic roles of T-box transcription factor TBX2 and its potential as a therapeutic target
    Bellis, Claire
    Mlaza, Mihlali, V
    Ali, Abid
    Abrahams, Amaal
    Prince, Sharon
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2025,
  • [23] WS5, a direct target of oncogenic transcription factor Myc, is related to human melanoma glycoprotein genes and has oncogenic potential
    F Reiter
    M Hartl
    A I Karagiannidis
    K Bister
    Oncogene, 2007, 26 : 1769 - 1779
  • [24] WS5, a direct target of oncogenic transcription factor Myc, is related to human melanoma glycoprotein genes and has oncogenic potential
    Reiter, F.
    Hartl, M.
    Karagiannidis, A. I.
    Bister, K.
    ONCOGENE, 2007, 26 (12) : 1769 - 1779
  • [25] USP10 as a Potential Therapeutic Target in Human Cancers
    Tao, Li
    Liu, Xiao
    Jiang, Xinya
    Zhang, Kun
    Wang, Yijing
    Li, Xiumin
    Jiang, Shulong
    Han, Tao
    GENES, 2022, 13 (05)
  • [26] Diagnostic and therapeutic potential of LINC01929 as an oncogenic LncRNA in human cancers
    Salimian, Niloufar
    Peymani, Maryam
    Ghaedi, Kamran
    Mirzaei, Sepideh
    Hashemi, Mehrdad
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 244
  • [27] Thrombospondin-1 as a Potential Therapeutic Target: Multiple Roles in Cancers
    Wang, Pengfei
    Zeng, Zheng
    Lin, Caiji
    Wang, Jiali
    Xu, Wenwen
    Ma, Wenqing
    Xiang, Qian
    Liu, Huidi
    Liu, Shu-Lin
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (18) : 2116 - 2136
  • [28] Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma
    Rahman, Mohammed Tanjimur
    Nakayama, Kentaro
    Rahman, Munmun
    Nakayama, Naomi
    Ishikawa, Masako
    Katagiri, Atsuko
    Iida, Kouji
    Nakayama, Satoru
    Otsuki, Yoshiro
    Shih, Ie-Ming
    Miyazaki, Kohji
    CANCER, 2012, 118 (11) : 2846 - 2857
  • [29] Metadherin: A Therapeutic Target in Multiple Cancers
    Dhiman, Gourav
    Srivastava, Neha
    Goyal, Mehendi
    Rakha, Emad
    Lothion-Roy, Jennifer
    Mongan, Nigel P.
    Miftakhova, Regina R.
    Khaiboullina, Svetlana F.
    Rizvanov, Albert A.
    Baranwal, Manoj
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [30] Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target
    Zhou, Heng
    Li, Ning
    Yuan, Yuan
    Jin, Ya-Ge
    Guo, Haipeng
    Deng, Wei
    Tang, Qi-Zhu
    BASIC RESEARCH IN CARDIOLOGY, 2018, 113 (05)